Work

Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals

Year: 2021
Type: article
Abstract: Assays for rapid biosafety level 2 (BSL2) evaluation of neutralizing properties of antibodies acquired via natural infection or through vaccination is urgently needed. Here, we propose a combinatorial approach in which sera are screened for SARS-CoV-2 spike protein (S) binding using a cell-based immunofluorescent (CBI) assay, and positive samples are further evaluated in a pseudotyped viral multicycle infection-mimicking protocol under BSL2 conditions.
Source: mSphere
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,500
OpenAlex ID: W3186551981
FWCI: 0.163
Cites: 36
Cited by: 3
Related to: 10